Balugrastim (CoGenesys)

N/A

Report date: 2025/03/18 15:00:19

Base Information

Drug NameBalugrastim (CoGenesys)
Drug Alias NameAlbugraninLong-acting Granulocyte Colony Stimulating Factor (G-CSF) - TevaPegfilgrastim biosimilar - TevaG-CSF/albumin human - TevaAlbumin fused G-CSF +[11] 
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Biosimilar
Mechanisms of ActionHaematopoiesis stimulantsColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsSolid tumoursNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEU
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesCogenesys
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeva Branded Pharmaceutical Products R&D IncTeva Pharma Bv
Active IndicationsN/A
Inactive IndicationsSolid tumoursNeutropenia

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG